Acadia Healthcare gets a consensus 'Hold' rating with mixed analyst price targets.

Acadia Healthcare (NASDAQ: ACHC) received a consensus 'Hold' rating from 16 brokerages, with 2 recommending sell, 7 hold, and 7 buy. Price targets vary, averaging around $21.15, with some recent downgrades and upgrades reflecting mixed analyst views. Institutional investors like Wellington Management and Goldman Sachs have increased their stakes recently. The company reported better-than-expected quarterly earnings and revenue growth, and provided guidance for 2026 EPS between $1.30 and $1.55. This mixed outlook suggests cautious investor sentiment amid steady operational performance.